SEARCH

SEARCH BY CITATION

References

  • 1
    Ash, R.C., Casper, J.T., Chiramber, C.R., Hansen, R., Bunin, N., Truitt, R.L., Lawton, C., Murray, K., Hunter, J., Baxter-Lowe, L.A., Gottschall, J.L., Oldham, K., Anderson, T., Camitta, B., Menitove, J. (1990) Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. New England Journal of Medicine, 322, 485 494.
  • 2
    Bacigalupo, A., Tedone, E., Isaza, A., Soracco, M., Van Lint, M.T., Sanna, A., Frassoni, F., Occhini, D., Gualandi, F., Lamparelli, T., Figari, O., Benvenuto, F., Raffo, M.R., Marmont, A.M. (1995) CMV antigenemia after allogeneic bone marrow transplantation: correlation of CMV-antigen positive cell numbers with transplant-related mortality. Bone Marrow Transplantation, 16, 155 161.
  • 3
    Beatty, P.G., Hansen, J.A., Longton, G.M., Thomas, E.D., Sanders, J.E., Martin, P.J., Bearman, S.I., Anasetti, C., Petersdorf, E.W., Mickelson, E.M., Pepe, M.S., Appelbaum, F.R., Buckner, C.D., Clift, R.A., Peterson, F.B., Stewart, P.S., Storb, R.F., Sullivan, K.M., Tesler, M.C., Witherspoon, R.P. (1991) Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation, 51, 443 447.
  • 4
    Couriel, D., Canosa, J., Engler, H., Collins, A., Dunbar, C., Barrett, A.J. (1996) Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies. Bone Marrow Transplantation, 18, 347 353.
  • 5
    Einsele, H., Steidle, M., Vallbracht, A., Saal, J.G., Ehninger, G., Muller, C.A. (1991) Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique. Blood, 77, 1104 1110.
  • 6
    Goodrich, J.M., Bowden, R.A., Fisher, L., Keller, C., Schoch, G., Meyers, J.D. (1993) Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Annals of Internal Medicine, 84, 1067 1071.
  • 7
    Goodrich, J.M., Mori, M., Gleaves, C.A., Du Mond, C., Cays, M., Ebeling, D.F., Buhles, W.C., DeArmond, B., Meyers, J.D. (1991) Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. New England Journal of Medicine, 325, 1601 1607.
  • 8
    Griffiths, P.D., Panjwani, D.D., Stirk, P.R., Ball, M.G., Ganczakowski, M., Blacklock, H.A., Prentice, H.G. (1984) Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci. Lancet, ii, 1242 1245.
  • 9
    Hale, G. & Waldmann, H. (1994) Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies: results of matched sibling transplants for malignant diseases. Bone Marrow Transplantation, 13, 597 611.
  • 10
    Hale, G. & Waldmann, H. (1996) Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection. Bone Marrow Transplantation, 17, 305 308.
  • 11
    Hertenstein, B., Hampl, W., Bunjes, D., Wiesneth, M., Duncker, C., Koszinowski, U., Heimpel, H., Arnold, R., Mertens, T. (1995) In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT. Bone Marrow Transplantation, 15, 387 393.
  • 12
    Marks, D.I., Cullis, J.O., Ward, K.N., Lacey, S., Szydlo, R., Hughes, T.P., Schwarer, A.P., Lutz, E., Barrett, A.J., Hows, J.M., Batchelor, R., Goldman, J.M. (1993) Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors: a comparison of complications in the first two years. Annals of Internal Medicine, 119, 207 214.
  • 13
    Meyers, J.D., Flournoy, N., Thomas, E.D. (1986) Risk factors for cytomegalovirus infection after human marrow transplantation. Journal of Infectious Diseases, 153, 478 488.
  • 14
    Meyers, J.D., Reed, E.C., Shepp, D.H., Thornquist, M., Dandliker, P.S., Vicary, C.A., Flournoy, N., Kirk, L.E., Kersey, J.H., Thomas, E.D., Balfour, H.H. (1988) Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. New England Journal of Medicine, 318, 70 75.
  • 15
    Prentice, H.G., Gluckman, E., Powles, R.L., Ljungman, P., Milpied, N.J., Camara, R., Mandelli, F., Kho, P., Kennedy, L., Bell, A.R. (1997) Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection. Bone Marrow Transplantation, 19, 129 133.
  • 16
    Prentice, H.G., Gluckman, E., Powles, R.L., Ljungman, P., Milpied, N.J., Fernandez Ranada, J.M., Madelli, F., Kho, P., Kennedy, L., Bell, A.R. (1994) Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. Lancet, 343, 749 753.
  • 17
    Prentice, H.G. & Kho, P. (1997) Clinical strategies for the management of cytomegalovirus infection and disease in allogeneic bone marrow transplant. Bone Marrow Transplantation, 19, 135 142.
  • 18
    Przepiorka, D., Ippoliti, C., Panina, A., Goodrich, J., Giralt, S., van Besien, K., Mehra, R., Deisseroth, A.B., Andersson, B., Luna, M., Tarrand, J.J., Champlin, R.E. (1994) Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation. Bone Marrow Transplantation, 13, 461 464.
  • 19
    Rubie, H., Attal, M., Campardou, A.M., Gayet-Mengelle, C., Payen, C., Sanguignol, F., Calot, J.P., Charlet, J.P., Robert, A., Huguet, F., Puel, J., Pris, J., Laurent, G. (1993) Risk factors for cytomegalovirus infection in BMT recipients transfused exclusively with seronegative blood products. Bone Marrow Transplantation, 11, 209 214.
  • 20
    Schmidt, G.M., Horak, D.A., Niland, J.C., Duncan, S.R., Forman, S.J., Zaia, J.A., and the City of Hope-Standford-Syntex CMV Study Group (1991) A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. New England Journal of Medicine, 324, 1005 1011.
  • 21
    Sullivan, K.M., Kopecky, K.J., Jocom, J., Fisher, L., Buckner, C.D., Meyers, J.D., Counts, G.W., Bowden, R.A., Petersen, F.B., Witherspoon, R.P., Budinger, M.D., Schwartz, R.S., Appelbaum, F.R., Clift, R.A., Hansen, J.A., Sanders, J.E., Thomas, E.D., Storb, R. (1990) Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. New England Journal of Medicine, 323, 705 712.
  • 22
    Takenaka, K., Gondo, H., Tanimoto, K., Nagafuji, K., Fujisaki, T., Mizuno, S., Miuamoto, T., Okamura, T., Hayashi, S., Eto, T., Osaki, K., Yamasaki, K., Shibuya, T., Harada, N., Teshima, T., Matsuishi, E., Minematsu, T., Minamishima, Y., Harada, M., Niho, Y. (1997) Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. Bone Marrow Transplantation, 19, 241 248.
  • 23
    Ward, K.N., Roberts, I.A.G., van Rhee, F. (1994) Ganciclovir and the prevention of CMV disease after allogeneic BMT: policy at the Hammersmith Hospital. Bone Marrow Transplantation, 13, 230 231.
  • 24
    Wingard, J.R., Piantadosi, S., Burns, W.H., Zahurak, M.L., Santos, G.W., Saral, R. (1990) Cytomegalovirus infections in patients treated by intensive cytoreductive therapy with marrow transplant. Reviews of Infectious Diseases, 12, (Suppl. 7), S793 S804.
  • 25
    Winston, D.J. & Gale, R.P. (1991) Prevention and treatment of cytomegalovirus infection and disease after bone marrow transplantation in the 1990s. Bone Marrow Transplantation, 8, 7 11.
  • 26
    Winston, D.J., Ho, W.G., Lin, C.H., Bartoni, K., Budinger, M.D., Gale, R.P., Champlin, R.E. (1987) Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Annals of Internal Medicine, 106, 12 18.